Rupestonic acid hydrazide derivative as well as preparation method and application thereof
By synthesizing artemisia ketohydrazide derivatives and testing their transmembrane serine protease 2 inhibitory activity, the problem of poor effectiveness of existing anti-coronavirus drugs was solved, and compounds with strong inhibitory activity were found, as potential drugs, and significantly Improves the effectiveness of anti-coronavirus and defines the target.
Patent Information
- Application Number
- CN202411164166.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-23
- Publication Date
- 2024-11-29
AI Technical Summary
Existing anti-coronavirus drugs have limited effects in inhibiting the activity of transmembrane serine protease 2, and their targets are unclear, making it difficult to meet the needs of clinical prevention and treatment.
A sprig of artemisia ketoacid hydrazide derivative was designed and synthesized. By condensing and dehydrating with different hydrazine (hydrazide) molecular blocks, 34 derivatives were prepared, and their transmembrane serine protease 2 inhibitory activity was tested, and some compounds were found. It has a significant inhibitory effect on coronavirus.
Compounds 3, 5, 8, 9, 17, etc. show strong inhibition rate on transmembrane serine protease 2 and have good anti-coronavirus activity. As a potential leading compound or candidate drug, it significantly improves the inhibitory effect and defines the target. point.
Smart Images

Figure CN119039173A_ABST
Abstract
Description
Technical Field
[0001] The invention discloses artemisia oleracea keto acid hydrazide derivatives, a preparation method and uses thereof, and belongs to the field of organic synthesis technology and biomedicine. Background Art
[0002] Xinjiang Artemisia selengensis has a long history of folk medicine, with anti-allergic, antiviral, antibacterial, anti-inflammatory, anti-cancer, liver protection and other effects. It is currently used clinically to treat urticaria, bruises, snake bites, abdominal pain, indigestion, colds and fevers. In the past 15 years, the research group of Aji Aikebaier of Xinjiang Institute of Physical and Chemical Technology has synthesized more than 300 derivatives with novel structures using the carboxylic acid site and 2-methylene of Artemisia selengensis keto acid as modification points, and studied their in vitro anti-influenza virus activity. The results showed that some compounds have good inhibitory activity against influenza A virus (H1N1 and H3N2) and influenza B virus. Wu Shuwen and others from the State Key Laboratory of Virology at Wuhan University discovered the lead of hydrazide derivatives through high-throughput screening, and discovered compounds with high anti-influenza virus activity by structural modification of hydrazide derivatives. Based on the good antiviral activity of artemisia ketoacid and hydrazide derivatives, the present invention designed and synthesized 34 artemisia ketoacid hydrazide derivatives, tested the transmembrane serine protease 2 inhibitory activity of these derivatives, and evaluated the anti-coronavirus activity.
[0003] References
[0004] 1. Liu Yongmin; Yu Dequan. Study on chemical components of Artemisia erinaceus. Acta Pharmaceutica Sinica, 1985, 7, 514-518.
[0005] 2. Yumaier, A.; Cui, ZC; Abudurixiti, A.; Yusuf, A., Development and Structural Modifications of Rupestonic Acid Derivatives as Novel Anti-Influenza Agents: A Mini Review of The Last 10 Years. ChemistrySelect 2022, 7(30).
[0006] 3.Han
[0007] The invention is based on a comprehensive analysis of relevant patents and documents at home and abroad, and obtains a series of artemisia ketoacid hydrazide derivatives by condensing and dehydrating naturally extracted artemisia ketoacid and hydrazine (acylhydrazide) compounds. Summary of the invention
[0008] The purpose of the present invention is to provide a natural product, artemisia ketoacid hydrazide derivatives, and a preparation method and use thereof. The derivatives are made of artemisia ketoacid as a raw material, and condense and dehydrate it with different hydrazine (hydrazide) molecular building blocks to obtain a series of artemisia ketoacid hydrazide derivatives. The obtained series of derivatives were tested for transmembrane serine protease 2 activity, and the results showed that compounds 1, 7, 10, 12, 13, 24, 24, 25, 26, 27, and 29 in the artemisia serine hydrazide derivatives showed a weak inhibition rate of 12.31%-29.80% on transmembrane serine protease 2; compounds 2, 4, 6, 11, 14, 15, 16, 18, 19, 20, 21, 22, 23, 28, 30, 31, 32, 33, and 34 showed a strong inhibition rate of 30.94%-58.88% on transmembrane serine protease 2; compounds 3, 5, 8, 9, and 17 showed a strong inhibition rate of 63.89%-83.75% on transmembrane serine protease 2, and have good application prospects in the prevention and treatment of coronavirus, as lead compounds or candidate drugs for anti-coronavirus with significant efficacy and clear targets.
[0009] The present invention discloses an artemisia ketoacid hydrazide derivative, the structural formula of which is:
[0010]
[0011] in:
[0012] Compound 1 is: N-benzoyl artemisinic acid hydrazide;
[0013] Compound 2 is: N-(4-trifluoromethylbenzoyl) artemisinic acid hydrazide;
[0014] Compound 3 is: N-(4-methylbenzoyl) artemisinic acid hydrazide;
[0015] Compound 4 is: N-(4-methoxybenzoyl) artemisinic acid hydrazide;
[0016] Compound 5 is: N-(4-N,N-diethylbenzoyl) artemisinic acid hydrazide;
[0017] Compound 6 is: N-indolecarboxylic acid hydrazide;
[0018] Compound 7 is: N-(4-tert-butylbenzoyl) artemisinic acid hydrazide;
[0019] Compound 8 is: N-(4-pyridinyl) artemisinic acid hydrazide;
[0020] Compound 9 is: N-(3-pyridinyl) artemisinic acid hydrazide;
[0021] Compound 10 is: N-(4-hydroxybenzoyl) artemisinic acid hydrazide;
[0022] Compound 11 is: N-(4-fluorobenzoyl) artemisinic acid hydrazide;
[0023] Compound 12 is: N-(4-iodobenzoyl) artemisinic acid hydrazide;
[0024] Compound 13 is: N-(4-chlorobenzoyl) artemisinic acid hydrazide;
[0025] Compound 14 is: N-(4-trifluoromethylbenzoyl) artemisinic acid hydrazide;
[0026] Compound 15 is: N-(4-cyanobenzoyl) artemisinic acid hydrazide;
[0027] Compound 16 is: N-(4-acetylaminobenzoyl) artemisinic acid hydrazide;
[0028] Compound 17 is: N-tert-butyl formate-artemisinic acid hydrazide;
[0029] Compound 18 is: N-(2,4,6-trichlorophenyl) artemisinic acid hydrazide;
[0030] Compound 19 is: N-(4-chlorophenyl) artemisinic acid hydrazide;
[0031] Compound 20 is: N-(4-methylphenyl) artemisinic acid hydrazide;
[0032] Compound 21 is: N-(4-iodophenyl) artemisinic acid hydrazide;
[0033] Compound 22 is: N-(4-tert-butylphenyl) artemisinic acid hydrazide;
[0034] Compound 23 is: N-(4-ethylphenyl) artemisinic acid hydrazide;
[0035] Compound 24 is: N-(4-methoxyphenyl) artemisinic acid hydrazide;
[0036] Compound 25 is: N-(4-bromophenyl) artemisinic acid hydrazide;
[0037] Compound 26 is: N-(4-nitrophenyl) artemisinic acid hydrazide;
[0038] Compound 27 is: N-(4-fluorophenyl) artemisinic acid hydrazide;
[0039] Compound 28 is: N-(4-trifluoromethoxyphenyl) artemisinic acid hydrazide;
[0040] Compound 29 is: N-(4-cyanophenyl) artemisinic acid hydrazide;
[0041] Compound 30 is: N-(4-isopropylphenyl) artemisinic acid hydrazide;
[0042] Compound 31 is: N-(2,6-dichlorophenyl) artemisinic acid hydrazide;
[0043] Compound 32 is: N-(4-ethylbenzoyl) artemisinic acid hydrazide;
[0044] Compound 33 is: N-(4-N,N-dimethylbenzoyl) artemisinic acid hydrazide;
[0045] Compound 34 is: N-(2-pyridyl)artemisinic acid hydrazide.
[0046] The preparation method of the artemisia ketoacid hydrazide derivatives is as follows:
[0047]
[0048] The naturally extracted artemisia ketoacid and hydrazine (acylhydrazide) compounds are subjected to condensation and dehydration to obtain a series of artemisia ketoacid acylhydrazide derivatives. The specific operation is carried out according to the following steps:
[0049] Dissolve 0.2mmol, 49.6mg of naturally extracted Artemisia selengensis ketone acid and 0.4mmol of hydrazine or hydrazide in 3mL of dry ethyl acetate, place in an ice bath at 0℃, add 1mL of pyridine, 0.4mmol of 1-n-propylphosphoric anhydride 50% ethyl acetate, 0.23mL solution in sequence, stir for 16h, and naturally warm to room temperature during stirring. After the reaction, quench the reaction with 0.5M hydrochloric acid in an ice bath at 0℃, extract with ethyl acetate 3 times, combine the organic layers, dry the organic layers with anhydrous sodium sulfate, spin dry the solvent, use 200-300 mesh silica gel as the stationary phase, and a mixed solution of ethyl acetate: petroleum ether in a volume ratio of 1:5 as the mobile phase, and purify by column chromatography to obtain the target derivative.
[0050] The artemisia serine hydrazide derivatives are used in the preparation of drugs for preventing and treating coronaviruses, wherein compounds 1, 7, 10, 12, 13, 24, 24, 25, 26, 27, and 29 show a weak inhibition rate of 12.31%-29.80% on transmembrane serine protease 2; compounds 2, 4, 6, 11, 14, 15, 16, 18, 19, 20, 21, 22, 23, 28, 30, 31, 32, 33, and 34 show a strong inhibition rate of 30.94%-58.88% on transmembrane serine protease 2; and compounds 3, 5, 8, 9, and 17 show a strong inhibition rate of 63.89%-83.75% on transmembrane serine protease 2.
[0051] The preparation method described in the present invention is to use naturally extracted artemisinin as a raw material, condense it with different hydrazines (acylhydrazides) to prepare artemisinin acylhydrazide derivatives, and test its transmembrane serine protease 2 inhibitory activity, thereby evaluating the anti-coronavirus activity of the series of derivatives. BRIEF DESCRIPTION OF THE DRAWINGS
[0052] Figure 1 This is a graph showing the inhibitory activity of the compound 5N-(4-N,N-diethylbenzoyl)-1,1-dione acid hydrazide of the present invention;
[0053] Figure 2 This is a graph showing the inhibitory activity of the compound 8N-(4-pyridinyl)-1,1-dione hydrazide. DETAILED DESCRIPTION
[0054] In order to make the present invention more clear, the present invention is further described in detail below in conjunction with embodiments. It should be understood that the described embodiments are only used to explain the present invention, but not to limit the present invention.
[0055] Example 1
[0056] N-Benzoyl artemisinic acid hydrazide:
[0057] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 54.4mg of benzoyl hydrazide were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propyl phosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 200 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 27.8mg of compound 1N-benzoyl artemisia selengensis ketone acid hydrazide;
[0058]
[0059] 2.77(m,2H),2.60–2.36(m,3H),2.14–1.94(m,3H),1.92–1.80(m,1H),1.79–1.69(m,2H),1.60(s,4H),0.60(d,J=7.0Hz,3H).
[0060] 13 C NMR (100MHz, CDCl3) δ208.58,174.49,167.18,165.58,148.60,138.23,132.82,131.63,129.03 ,127.78,118.26,46.21,41.72,38.85,36.87,35.65,34.23,31.63,25.99,25.30,12.44,8.41.
[0061] Example 2
[0062] N-(4-trifluoromethylbenzoyl) artemisinic acid hydrazide:
[0063] 0.2mmol, 49.6mg of naturally extracted Artemisia selengensis ketoacid and 0.4mmol, 88.0mg of p-trifluoromethoxybenzoic acid were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric acid anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate 3 times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 300 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 41.1mg of compound 2N-(4-trifluoromethylbenzoyl) Artemisia selengensis ketoacid hydrazide;
[0064]
[0065] 2.82(m,2H),2.63–2.40(m,2H),2.16–2.08(m,1H),2.03(d,J=18.8Hz,1H) ,1.93–1.85(m,1H),1.84–1.74(m,3H),1.63(s,4H),0.63(d,J=7.1Hz,3H).
[0066] 13 C NMR (100MHz, CDCl3) δ208.51,174.11,167.41,164.20,152.58,148.74,138.42,129.91,129.79,12 1.04,118.38,46.30,41.75,39.03,38.34,36.95,35.70,34.25,31.72,30.14,25.32,12.48,8.46.
[0067] Example 3
[0068] N-(4-Methylbenzoyl) artemisinic acid hydrazide:
[0069] 0.2mmol, 49.6mg of naturally extracted Artemisia selengensis ketone acid and 0.4mmol, 60.0mg of p-methylbenzoyl hydrazide were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propyl phosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the reaction was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 200 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 36.3mg of compound 3N-(4-methylbenzoyl) Artemisia selengensis ketone acid hydrazide;
[0070]
[0071] 1H NMR(400MHz, CDCl3)δ9.43(s,1H),9.32(s,1H),7.74(d,J=8.2Hz,2H),7.22(d,J=8.0Hz,2H),5.81(s,1H),5.46(s,1H),3.17–3.04(m,1H),2. 97–2.81(m,2H),2.64–2.44(m,2H),2.39(s,3H),2.15–2.07(m,1H),2. 07–1.96(m,1H),1.85–1.72(m,3H),1.63(s,3H),0.63(d,J=7.1Hz,3H).
[0072] 13 C NMR (100MHz, CDCl3) δ207.96,173.74,165.99,164.55,148.14,143.02,137.72,129.22,128.14 ,127.10,117.51,45.65,41.15,38.38,37.76,36.33,35.10,31.06,29.50,21.37,11.86,7.82.
[0073] Example 4
[0074] N-(4-methoxybenzoyl) artemisinic acid hydrazide
[0075] 0.2mmol, 49.6mg of naturally extracted Artemisia selengensis ketoic acid and 0.4mmol, 66.4mg of p-methoxybenzoic hydrazide were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propyl phosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the reaction was extracted 3 times with ethyl acetate. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 250 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 27.2mg of compound 4N-(4-methoxybenzoyl) Artemisia selengensis ketoic acid hydrazide;
[0076]
[0077] 2.81(m,2H),2.62–2.40(m,2H),2.15–2.08(m,1H),2.06–1.98(m,1H),1.85–1.74(m,3H),1.63(s,3H),0.63(d,J=7.1Hz,3H).
[0078] 13 C NMR (100MHz, CDCl3) δ207.91,173.68,166.05,164.27,162.81,148.24,137.73,129.04,128.53,12 3.20,117.39,113.80,55.27,45.64,41.16,38.39,37.76,36.33,35.10,31.08,29.50,11.87,7.83.
[0079] Example 5
[0080] N-(4-N,N-diethylbenzoyl) artemisinic acid hydrazide:
[0081] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 82.9mg of 4-N, N-diethylbenzoyl hydrazide were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propyl phosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 300 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 23.5mg of compound 5N-(4-N, N-diethylbenzoyl) artemisia selengensis ketone acid hydrazide;
[0082]
[0083] –3.09(m,1H),2.96–2.81(m,2H),2.61–2.38(m,2H),2.10(dq,J=6.8,3.6Hz,1H),2.07–1.97(m,1H ),1.86–1.74(m,3H),1.63(s,3H),1.60–1.51(m,1H),1.18(t,J=7.1Hz,6H),0.63(d,J=7.1Hz,3H).
[0084] 13C NMR (100MHz, CDCl3) δ208.27,174.33,166.23,165.18,150.73,148.37,137.81,131.73,129.26,128.51,117.5 4,116.58,110.45,45.83,44.44,41.37,38.46,38.03,36.51,35.31,33.80,31.27,29.69,12.46,12.05,8.00.
[0085] Example 6
[0086] N-Indole-6-formyl artemisinic acid hydrazide:
[0087] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 70.0mg of indole-6-carboxylic hydrazide were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propyl phosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the reaction was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 200 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 36.4mg of compound 6N-indole-6-carboxylic artemisia selengensis ketone acid hydrazide;
[0088]
[0089] 7.51(m,2H),7.33(t,J=2.8Hz,1H),6.54(t,J=2.4Hz,1H),5.82(s,1H),5.41(s,1H),2.95(s,1H),2.88–2.71(m,2H),2.48(dd,J= 18.8,6.5Hz,1H),2.42–2.29(m,1H),2.08–1.91(m,3H),1.80–1.61(m,2H),1.56(s,3H),1.54–1.48(m,1H),0.57(d,J=7.1Hz,3H).
[0090] 13C NMR (100MHz, CDCl3) δ208.40,174.41,158.96,148.35,135.31,131.29,127.82,124.14,120.66,118.19 ,117.80,111.59,102.70,101.84,99.99,45.73,41.31,37.97,36.38,35.16,31.21,29.70,11.98,7.95.
[0091] Example 7
[0092] N-(4-tert-Butylbenzoyl) artemisinic acid hydrazide:
[0093] 0.2mmol, 49.6mg of naturally extracted Artemisia selengensis ketone acid and 0.4mmol, 76.8mg of p-tert-butylbenzaldehyde were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 300 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 32.9mg of compound 7N-(4-tert-butylbenzoyl) Artemisia selengensis ketone acid hydrazide;
[0094]
[0095] 1.98(m,1H),1.87–1.74(m,3H),1.64(d,J=1.8Hz,3H),1.60(d,J=11.2Hz,1H),1.32(s,9H),0.64(d,J=7.1Hz,3H).
[0096] 13 C NMR (100MHz, CDCl3) δ208.14,173.94,166.35,164.78,156.20,148.33,137.92,131.82,128.43,128.26,127.1 7,125.67,117.75,49.27,45.85,41.34,38.54,37.98,36.51,35.29,33.81,31.10,25.58,24.90,12.06,8.02.
[0097] Example 8
[0098] N-(Pyridine-4-carbonyl) artemisinic acid hydrazide
[0099] 0.2mmol, 49.6mg of naturally extracted Artemisia selengensis ketoacid and 0.4mmol, 54.8mg of pyridine-4-carboxylic hydrazide were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propyl phosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the reaction was extracted 3 times with ethyl acetate. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 200 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 28.3mg of compound 8N-(pyridine-4-carboxylic acyl) Artemisia selengensis ketoacid hydrazide;
[0100]
[0101] 2.43(m,2H),2.17–2.09(m,1H),2.04(d,J=18.9Hz,1H),1.80(tq,J=8.5 ,5.0,4.0Hz,3H),1.63(s,4H),1.61–1.54(m,1H),0.64(d,J=7.1Hz,3H).
[0102] 13 C NMR (100MHz, CDCl3) δ208.68,174.33,167.42,163.51,150.86,148.67,139.10,138.40,132 .20,128.94,121.61,118.56,46.33,41.74,39.05,38.37,36.93,35.65,31.66,12.49,8.47.
[0103] Example 9
[0104] N-(Pyridine-3-carbonyl) artemisinic acid hydrazide
[0105] 0.2mmol, 49.6mg of naturally extracted Artemisia selengensis ketoacid and 0.4mmol, 54.8mg of pyridine-4-carboxylic hydrazide were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the reaction was extracted 3 times with ethyl acetate. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 200 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 33.6mg of compound 9N-(pyridine-3-carboxylic acid ketoacid hydrazide);
[0106]
[0107] (dd,J=8.0,4.9Hz,1H),5.82(s,1H),5.48(s,1H),3.12(d,J=6.3Hz,1H),2.93–2.80(m,2H),2.61–2.39(m,2H),2.15–2 .07(m,1H),2.02(d,J=18.9Hz,1H),1.79(d,J=10.9Hz,3H),1.61(s,3H),1.56(d,J=6.0Hz,1H),0.62(d,J=7.1Hz,3H).
[0108] 13 C NMR (101MHz, CDCl3) δ208.20,173.93,167.02,163.43,152.81,148.31,137.93,135.47,131 .70,127.42,123.61,117.99,45.86,41.31,38.58,37.94,36.49,35.24,31.22,12.05,8.03.
[0109] Example 10
[0110] N-(4-Hydroxybenzoyl) artemisinic acid hydrazide:
[0111] 0.2mmol, 49.6mg of naturally extracted Artemisia selengensis ketoic acid and 0.4mmol, 60.8mg of p-hydroxybenzoic hydrazide were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 300 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 26.2mg of compound 10 N-(4-hydroxybenzoyl) Artemisia selengensis ketoic acid hydrazide;
[0112]
[0113] 2H), 2.14(dd,J=7.3,3.5Hz,1H),2.08–2.00(m,1H),1.94–1.83(m,3H),1.76–1.69(m,1H),1.67–1.63(m,3H),0.67(d,J=7.1Hz,3H).
[0114] 13 C NMR (100MHz, CDCl3) δ213.65,181.06,173.83,171.67,171.57,165.17,152.99,151.62,141.01, 133.26,126.90,120.45,118.75,49.83,44.95,42.58,41.73,40.21,39.25,34.78,14.86,10.44.
[0115] Embodiment 11
[0116] N-(4-Fluorobenzoyl)-artemisinic acid hydrazide
[0117] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 61.7mg of p-fluorobenzoic acid hydrazide were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propyl phosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 300 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 22.9mg of compound 11N-(4-fluorobenzoyl) artemisia selengensis ketone acid hydrazide;
[0118]
[0119] (s,1H),5.50(s,1H),3.18–3.13(m,1H),2.94–2.84(m,3H),2.63–2.55(m,1H),2.48(dd,J=19.5,12.1Hz,1H),2 .16–2.10(m,1H),2.09–2.00(m,1H),1.86–1.76(m,3H),1.64(s,3H),1.62–1.55(m,1H),0.65(d,J=7.1Hz,3H).
[0120] 13 C NMR (125MHz, CDCl3) δ208.25,173.94,169.34,166.75,164.07,148.23,137.95,132.28,129.92, 128.18,127.28,117.95,115.78,45.86,41.32,38.54,37.93,36.50,35.25,31.25,12.06,8.04.
[0121] Example 12
[0122] N-(4-iodobenzoyl) artemisinic acid hydrazide:
[0123] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 104.8mg of p-iodobenzoyl hydrazide were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the reaction was extracted 3 times with ethyl acetate. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 250 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 35.4mg of compound 12N-(4-iodobenzoyl) artemisia selengensis ketone acid hydrazide;
[0124]
[0125] 1H),5.48(s,1H),3.16–3.11(m,1H),2.92–2.81(m,2H),2.59(dd,J=18.8,6.5Hz,1H),2.46(dd,J=19.7,12.4Hz,1H),2.12(dq,J=7.1,3. 6Hz,1H),2.04(d,J=18.9Hz,1H),1.95–1.87(m,1H),1.82–1.75(m,2H),1.73–1.67(m,1H),1.64(d,J=1.8Hz,3H),0.64(d,J=7.1Hz,3H).
[0126] 13 C NMR (100MHz, CDCl3) δ208.14,173.80,169.29,166.85,164.45,148.20,137.92,132.12,130.49 ,128.87,128.28,117.99,99.90,45.87,41.34,38.54,37.90,36.52,35.26,31.30,12.07,8.07.
[0127] Example 13
[0128] N-(4-Chlorobenzoyl) artemisinic acid hydrazide
[0129] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 68.2mg of p-chlorobenzoyl hydrazide were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 300 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 29.0mg of compound 13N-(4-chlorobenzoyl) artemisia selengensis ketone acid hydrazide;
[0130]
[0131] =8.5Hz,2H),5.82(s,1H),5.49(s,1H),3.16–3.09(m,1H),2.94–2.79(m,2H),2.58(dd,J=18.8,6.6Hz,1H),2.47(dd,J=19.6,12 .3Hz,1H),2.16–2.09(m,1H),2.04(d,J=18.9Hz,1H),1.86–1.73(m,3H),1.64(s,3H),1.61–1.55(m,1H),0.64(d,J=7.1Hz,3H).
[0132] 13 C NMR (100MHz, CDCl3) δ208.11,173.72,166.71,164.02,148.25,138.93,137.97,132.22,129.48, 129.00,128.80,128.16,117.93,45.86,41.32,38.57,37.90,36.51,35.26,31.28,12.05,8.04.
[0133] Embodiment 14
[0134] N-(4-trifluoromethylbenzoyl) artemisinic acid hydrazide:
[0135] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 81.7mg of trifluoromethylbenzoyl hydrazide were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propyl phosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 300 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 34.3mg of compound 14N-(4-trifluoromethylbenzoyl) artemisia selengensis ketone acid hydrazide;
[0136]
[0137] 1H),5.52(s,1H),3.21–3.10(m,1H),2.97–2.84(m,2H),2.68–2.39(m,2H),2.19–2.09(m,1H),2.10–2. 00(m,1H),1.79(dtt,J=14.9,10.7,4.9Hz,3H),1.65(s,4H),1.61–1.53(m,1H),0.65(d,J=7.1Hz,3H).
[0138] 13 C NMR (100MHz, CDCl3) δ208.19,173.77,169.26,166.87,163.65,148.21,138.00,134.33,132.38,128 .08,127.87,125.74,118.10,45.87,41.30,38.59,37.91,36.50,35.24,31.26,29.70,12.05,8.04.
[0139] Embodiment 15
[0140] N-(4-cyanobenzoyl) artemisinic acid hydrazide:
[0141] 0.2mmol, 49.6mg of naturally extracted Artemisia selengensis ketone acid and 0.4mmol, 64.5mg of p-cyanobenzoic acid hydrazide were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric acid anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the reaction was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 200 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 27.1mg of compound 15 N-(4-cyanobenzoyl) Artemisia selengensis ketone acid hydrazide;
[0142]
[0143] 1H),5.54(s,1H),3.21–3.10(m,1H),2.98–2.82(m,2H),2.69–2.42(m,2H),2.18–2.10(m,1H) ,2.11–1.98(m,1H),1.92–1.72(m,3H),1.64(s,4H),1.63–1.54(m,1H),0.65(d,J=7.1Hz,3H). 13 C NMR (100MHz, CDCl3) δ208.26,173.89,166.78,163.52,163.14,154.56,148.19,137.98,135.03,132 .49,128.08,118.16,117.68,116.02,45.90,41.30,38.59,37.92,36.50,35.22,31.24,12.07,8.06.
[0144] Example 16
[0145] N-(4-acetylaminobenzoyl) artemisinic acid hydrazide:
[0146] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 77.3mg of 4-acetylaminobenzoyl hydrazide were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propyl phosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the reaction was extracted 3 times with ethyl acetate. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 200 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 42.6mg of compound 16N-(4-acetylaminobenzoyl) artemisia selengensis ketone acid hydrazide;
[0147]
[0148] 1 H NMR (400MHz, Methanol-d4) δ7.85(d,J=8.8Hz,2H),7.68(d,J=8.7Hz,2H),5.81(s,1H),5.55(s,1H),3.27(d,J=5.8Hz,2H),3.05–2.91(m,2H) ,2.65–2.55(m,2H),2.14(s,3H),2.03(d,J=19.0Hz,1H),1.94–1.82(m,3H),1.76–1.69(m,1H),1.65(d,J=1.8Hz,3H),0.66(d,J=7.1Hz,3H).
[0149] 13 C NMR (125MHz, CDCl3) δ213.64,186.44,181.07,175.69,174.45,173.80,171.23,152.94,146.28,141.01, 132.15,131.06,122.74,120.51,49.83,44.94,42.58,41.71,40.21,39.25,34.77,26.55,14.86,10.44.
[0150] Embodiment 17
[0151] N-tert-Butyl formate-artemisinic acid hydrazide:
[0152] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 52.9mg of tert-butyl carbazate were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propyl phosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 300 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 57.2mg of compound 17N-tert-butyl formate artemisia selengensis ketone acid hydrazide;
[0153]
[0154] 1.88–1.78(m,3H),1.65(s,4H),1.61(s,1H),1.48(s,9H).
[0155] 13 C NMR (100MHz, CDCl3) δ208.30,174.33,168.57,155.60,149.00,137.83,117.00,81.97 ,45.87,41.34,38.71,37.96,36.48,35.27,31.04,29.67,28.18,28.14,12.05,7.97.
[0156] Embodiment 18
[0157] N-(2,4,6-Trichlorophenyl) artemisinic acid hydrazide:
[0158] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 84.6mg of 2,4,6-trichlorophenylhydrazine were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 200 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used to purify the compound 18 N-(2,4,6-trichlorophenyl) artemisia selengensis ketone acid hydrazide 44.9mg;
[0159]
[0160] 1 H NMR (400MHz, CDCl3) δ7.99(d,J=4.8Hz,1H),7.29(s,2H),6.77(d,J=4.8Hz,1 H),5.66(s,1H),5.45(s,1H),3.16–3.09(m,1H),2.91–2.75(m,2H),2.64–2.3 5(m,2H),2.16–2.08(m,1H),2.07–1.98(m,1H),1.87–1.82(m,1H),1.82–1.7 9(m,1H),1.78–1.75(m,1H),1.65(s,1H),1.62(s,3H),0.64(d,J=7.1Hz,3H).
[0161] 13 C NMR (100MHz, CDCl3) δ207.99,173.71,168.19,149.33,144.04,142.67,139.89,137.89,128 .82,128.54,126.27,117.10,45.84,41.29,38.14,36.52,35.28,31.06,29.68,12.03,7.99.
[0162] Embodiment 19
[0163] N-(4-Chlorophenyl) artemisinic acid hydrazide:
[0164] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 57.0mg of 4-chlorophenylhydrazine were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 200 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 31.8mg of compound 19N-(4-chlorophenyl) artemisia selengensis ketone acid hydrazide;
[0165]
[0166] (s,1H),3.14(d,J=6.4Hz,1H),2.97–2.81(m,2H),2.67–2.44(m,2H),2.17–2.08(m,1H),2. 08–1.98(m,1H),1.86–1.78(m,3H),1.73–1.66(m,1H),1.64(s,3H),0.65(d,J=7.1Hz,3H).
[0167] 13 C NMR (100MHz, CDCl3) δ208.17,173.94,169.18,156.50,149.43,148.23,146.63,137.88,129 .17,126.36,116.71,114.96,45.87,41.28,37.99,36.52,35.28,31.22,29.68,12.02,7.98.
[0168] Embodiment 20
[0169] N-(4-Methylphenyl) artemisinic acid hydrazide:
[0170] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 48.8mg of 4-methylphenylhydrazine were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the reaction was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 200 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 29.4mg of compound 20N-(4-methylphenyl) artemisia selengensis ketone acid hydrazide;
[0171]
[0172] 2H),6.85(d,J=8.5Hz,2H),5.65(s,1H),5.46(s,1H),3.25(s,3H),3.18–3.13(m,2H),2.99–2.87(m,2H),2.67–2.47(m,2H) ,2.13(s,1H),2.04(d,J=18.9Hz,1H),1.92(dd,J=11.9,4.3Hz,1H),1.88–1.82(m,2H),1.66(s,3H),0.65(d,J=7.2Hz,3H).
[0173] 13 C NMR (125MHz, CDCl3) δ208.15,174.05,167.95,150.08,149.21,137.82,131.27,129.25,120.00 ,115.89,115.34,112.89,45.87,41.35,39.12,36.53,35.29,33.91,31.11,24.93,12.08,8.00.
[0174] Embodiment 21
[0175] N-(4-iodophenyl) artemisinic acid hydrazide:
[0176] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 93.6mg of 4-iodophenylhydrazine were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the reaction was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 200 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 41.8mg of compound 21 N-(4-iodophenyl) artemisia selengensis ketone acid hydrazide;
[0177]
[0178] 3.34(m,1H),3.15(s,1H),3.02–2.80(m,2H),2.66–2.44(m,2H),2.19–2.01(m,3H),1.98–1.86(m,3H),0.65(d,J=7.1Hz,4H).
[0179] 13 C NMR (100MHz, CDCl3) δ208.00,173.76,169.01,156.33,149.26,146.46,137.71,129.05,126 .18,116.54,114.79,99.80,45.70,41.22,38.84,36.35,35.11,31.05,29.51,11.85,7.84.
[0180] Embodiment 22
[0181] N-(4-tert-butylphenyl) artemisinic acid hydrazide:
[0182] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 65.7mg of 4-tert-butylphenylhydrazine were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 200 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 39.8mg of compound 22 N-(4-tert-butylphenyl) artemisia selengensis ketone acid hydrazide;
[0183]
[0184] 3.15(s,1H),3.01–2.83(m,2H),2.64–2.44(m,2H),2.19–1.97(m,2H),1.88–1. 77(m,3H),1.74–1.66(m,1H),1.64(s,3H),1.27(s,9H),0.65(d,J=7.1Hz,4H).
[0185] 13 C NMR (100MHz, CDCl3) δ208.24,174.15,169.19,149.68,149.41,145.37,144.50,137.84,126.11,117.76,1 16.32,113.57,63.73,53.43,45.88,41.35,39.01,38.00,36.53,35.28,31.46,31.12,29.70,12.07,8.01.
[0186] Embodiment 23
[0187] N-(4-Ethylphenyl)-artemisinic acid hydrazide
[0188] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 54.5mg of 4-ethylphenylhydrazine were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 300 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 27.9mg of compound 23N-(4-ethylphenyl) artemisia selengensis ketone acid hydrazide;
[0189]
[0190] (m,3H),2.10–2.01(m,1H),1.96(d,J=18.7Hz,1H),1.81–1.70(m,3H),1.57(s,3H),1.12(t,J=7.6Hz,3H),0.57(d,J=7.1Hz,3H).
[0191] 13 C NMR (100MHz, CDCl3) δ208.14,174.03,169.13,149.71,145.72,138.43,137.84,137.56,128.63,12 3.51,116.16,113.94,45.87,41.36,38.00,36.53,35.27,31.13,29.60,27.98,15.65,12.02,7.99.
[0192] Embodiment 24
[0193] N-(4-methoxyphenyl) artemisinic acid hydrazide:
[0194] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 55.3mg of 4-methoxyphenylhydrazine were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 200 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 32.7mg of compound 24N-(4-methoxyphenyl) artemisia selengensis ketone acid hydrazide;
[0195]
[0196] =31.6,19.2,9.5Hz,2H),2.16–2.08(m,1H),2.04(d,J=18.8Hz,1H),1.88–1.76(m,3H),1.77–1.68(m,1H),1.64(s,3H),0.65(d,J=7.2Hz,3H).
[0197] 13 C NMR (125MHz, CDCl3) δ208.17,174.02,169.18,154.97,152.12,149.71,141.48,137.85,116.28 ,115.72,114.69,114.62,63.72,55.64,45.86,41.35,39.00,36.53,35.28,31.14,12.07,8.01.
[0198] Embodiment 25
[0199] N-(4-bromophenyl) artemisinic acid hydrazide:
[0200] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 74.8mg of 4-bromophenylhydrazine were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 300 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 41.1mg of compound 25 N-(4-bromophenyl) artemisia selengensis ketone acid hydrazide;
[0201]
[0202] (m,2H),2.17–2.08(m,1H),2.08–1.98(m,1H),1.86–1.78(m,3H),1.73–1.66(m,1H),1.64(s,3H),0.65(d,J=7.1Hz,3H).
[0203] 13 C NMR (100MHz, CDCl3) δ208.03,173.75,149.69,149.46,147.18,137.89,136.07,132.07,116 .68,115.30,113.57,99.98,45.85,41.39,39.03,37.98,36.53,35.27,31.22,12.02,7.96.
[0204] Embodiment 26
[0205] N-(4-nitrophenyl) artemisinic acid hydrazide:
[0206] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 61.3mg of 4-nitrophenylhydrazine were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the reaction was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 300 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 36.8mg of compound 26 N-(4-nitrophenyl) artemisia selengensis ketone acid hydrazide;
[0207]
[0208] 2.64–2.49(m,2H),2.19–2.10(m,1H),2.09–1.98(m,1H),1.89–1.73(m,3H),1.74–1.66(m,1H),1.65(s,3H),0.65(d,J=7.2Hz,3H).
[0209] 13 C NMR (100MHz, CDCl3) δ208.17,173.85,169.01,157.49,153.49,149.00,141.39,137.92,129.70 ,125.84,117.44,112.10,45.88,41.37,39.05,37.96,36.51,35.25,31.31,29.69,12.05,8.03.
[0210] Embodiment 27
[0211] N-(4-Fluorophenyl) artemisinic acid hydrazide:
[0212] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 50.5mg of 4-fluorophenylhydrazine were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the reaction was extracted 3 times with ethyl acetate. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 200 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 29.3mg of compound 27N-(4-fluorophenyl) artemisia selengensis ketone acid hydrazide;
[0213]
[0214] 1H),2.08–1.99(m,1H),1.90–1.74(m,3H),1.67(s,1H),1.64(s,3H),0.65(d,J=7.1Hz,3H). 13C NMR (100MHz, CDCl3) δ208.63,174.40,169.64,156.96,149.89,147.09,138.35,129.68,126 .82,117.18,115.42,100.44,46.33,41.74,38.45,36.99,35.74,31.68,30.14,12.49,8.47.
[0215] Embodiment 28
[0216] N-(4-trifluoromethoxyphenyl) artemisinic acid hydrazide:
[0217] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 76.9mg of 4-trifluoromethoxyphenylhydrazine were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 300 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 33.7mg of compound 28 N-(4-trifluoromethoxyphenyl) artemisia selengensis ketone acid hydrazide;
[0218]
[0219] 2.17–2.09(m,1H),2.08–2.00(m,1H),1.87–1.77(m,3H),1.74–1.67(m,1H),1.64(s,3H),0.65(d,J=7.1Hz,3H).
[0220] 13 C NMR (100MHz, CDCl3) δ208.00,173.65,169.19,149.47,148.77,146.68,137.92,122.30,119.28 ,116.74,114.39,111.98,45.85,41.39,39.10,37.98,36.54,35.30,31.25,29.67,12.02,7.96.
[0221] Embodiment 29
[0222] N-(4-Cyanophenyl) artemisinic acid hydrazide
[0223] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 53.2mg of 4-cyanophenylhydrazine were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the reaction was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 200 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was performed to purify the compound 29 N-(4-cyanophenyl) artemisia selengensis ketone acid hydrazide 22.6mg;
[0224]
[0225] 3H),1.72–1.67(m,1H),1.64(s,3H),0.65(d,J=7.1Hz,3H).
[0226] 13 C NMR (100MHz, CDCl3) δ208.04,173.67,169.06,151.72,149.12,137.92,133.68,123.16,119.36 ,117.24,113.10,103.70,99.99,45.86,41.26,38.95,37.94,36.52,35.23,31.31,12.02,7.99.
[0227] Embodiment 30
[0228] N-(4-isopropylphenyl) artemisinic acid hydrazide:
[0229] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 60.1mg of 4-isopropylphenylhydrazine were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 300 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 40.3mg of compound 30 N-(4-isopropylphenyl) artemisia selengensis ketone acid hydrazide;
[0230]
[0231] 1.89–1.77(m,3H),1.70(s,1H),1.64(s,3H),1.20(d,J=7.0Hz,6H),0.65(d,J=7.1Hz,3H). 13 C NMR (100MHz, CDCl3) δ208.04,173.86,169.13,168.83,149.77,142.24,137.86,127.29,127.21 ,127.01,116.22,113.92,45.86,39.09,37.97,36.55,35.29,31.14,29.70,24.08,12.06,7.97.
[0232] Embodiment 31
[0233] N-(2,6-dichlorophenyl) artemisinic acid hydrazide:
[0234] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 70.0mg of 2,6-dichlorophenylhydrazine were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propylphosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 300 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 38.3mg of compound 31 N-(2,6-dichlorophenyl) artemisia selengensis ketone acid hydrazide;
[0235]
[0236] (ddd,J=18.8,6.6,1.2Hz,1H),2.37(dd,J=19.6,12.1Hz,1H),2.08–2.00(m,1H),2. 00–1.88(m,1H),1.78–1.67(m,3H),1.59(s,1H),1.54(s,3H),0.56(d,J=7.1Hz,3H).
[0237] 13C NMR (100MHz, CDCl3) δ208.02,173.86,168.10,152.81,149.44,140.97,137.84,136.78,128. 99,125.85,124.12,116.88,53.40,45.84,38.91,38.13,36.52,35.31,31.00,29.68,12.06.
[0238] Embodiment 32
[0239] N-(4-ethylbenzoyl) artemisinic acid hydrazide:
[0240] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 65.7mg of 4-ethylbenzoyl hydrazide were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propyl phosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 200 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 46.2mg of compound 32 N-(4-ethylbenzoyl) artemisia selengensis ketone acid hydrazide;
[0241]
[0242] 1H),5.45(s,1H),3.14(s,1H),2.98–2.80(m,2H),2.61–2.52(m,3H),2.52–2.43(m,1H),2.17–2.09(m,1H),2.03( d,J=18.7Hz,1H),1.89–1.75(m,3H),1.77–1.65(m,1H),1.64(s,3H),1.18(t,J=7.6Hz,3H),0.64(d,J=7.1Hz,3H).
[0243] 13 C NMR (100MHz, CDCl3) δ208.06,173.82,166.14,164.72,149.39,148.42,137.93,131.76,128.59,128.24 ,127.37,117.65,117.51,45.84,38.64,37.96,36.53,35.28,31.27,29.67,28.79,15.19,12.05,7.94.
[0244] Embodiment 33
[0245] N-(4-N,N-dimethylbenzoyl) artemisinic acid hydrazide:
[0246] 0.2mmol, 49.6mg of naturally extracted artemisia selengensis ketone acid and 0.4mmol, 71.7mg of 4-N,N-dimethylbenzoyl hydrazide were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propyl phosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the mixture was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 300 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 39.5mg of compound 33N-(4-N,N-dimethylbenzoyl) artemisia selengensis ketone acid hydrazide;
[0247]
[0248] J=9.0Hz,2H),5.82(s,1H),5.43(s,1H),3.16–3.09(m,1H),3.02(s,6H),2.94–2.80(m,2H),2.65–2.37(m,2H),2. 10(d,J=8.1Hz,1H),2.06–1.95(m,1H),1.86–1.73(m,3H),1.62(s,3H),1.60–1.51(m,1H),0.63(d,J=7.1Hz,3H).
[0249] 13 C NMR (100MHz, CDCl3) δ208.09,174.10,166.20,165.12,153.02,148.44,137.81,128.93,117.65 ,117.36,110.95,45.81,41.35,39.96,38.52,37.97,36.52,35.32,31.30,29.67,12.05,8.00.
[0250] Embodiment 34
[0251] N-(2-pyridyl) artemisinic acid hydrazide:
[0252] 0.2mmol, 49.6mg of naturally extracted Artemisia selengensis ketoacid and 0.4mmol, 43.7mg of 2-hydrazine pyridine were dissolved in 3mL of dry ethyl acetate, placed in an ice bath at 0°C, 1mL of pyridine and 0.4mmol, 0.23mL of 1-n-propyl phosphoric anhydride 50% ethyl acetate solution were added in sequence, and stirred for 16h. The temperature naturally rose to room temperature during the stirring process. After the reaction was completed, 0.5M hydrochloric acid was used to quench the reaction in an ice bath at 0°C, and the reaction was extracted with ethyl acetate three times. The organic layers were combined, dried over anhydrous sodium sulfate, and the solvent was dried by spin drying. 200 mesh silica gel was used as the stationary phase, and a mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1:5 was used as the mobile phase. Column chromatography was used for purification to obtain 27.1mg of compound 34 N-(2-pyridyl) Artemisia selengensis ketoacid hydrazide;
[0253]
[0254] 5.47(s,1H),3.15(d,J=6.9Hz,1H),2.98–2.87(m,2H),2.64–2.43(m,2H),2.17–2.09(m,1H), 2.08–1.99(m,1H),1.90–1.76(m,3H),1.77–1.68(m,1H),1.65(s,3H),0.65(d,J=7.1Hz,3H). 13 C NMR (100MHz, CDCl3) δ208.07,173.98,168.10,158.41,149.43,147.82,147.33,138.03 ,116.62,107.78,99.98,45.86,41.41,38.92,38.02,36.54,35.33,31.16,12.07,8.00.
[0255] Embodiment 35
[0256] The preparation method and use of the Artemisia sphaerocephala ketoacid hydrazide derivatives of the present invention are used to test the inhibitory activity of the 34 compounds obtained on the transmembrane serine protease 2. The results show that the 34 Artemisia sphaerocephala ketoacid hydrazide derivatives obtained have different inhibitory activities on the transmembrane serine protease 2 as shown in Table 1.
[0257] Table 1 Inhibition rate of transmembrane serine protease 2 by hydrazide derivatives of Artemisia serine protease 2 (10uM)
[0258]
[0259]
[0260] Among the 34 compounds tested, 1, 7, 10, 12, 13, 24, 24, 25, 26, 27, and 29 showed weak inhibition rates (12.31%-29.80%) against transmembrane serine protease 2; compounds 2, 4, 6, 11, 14, 15, 16, 18, 19, 20, 21, 22, 23, 28, 30, 31, 32, 33, and 34 showed strong inhibition rates (30.94%-58.88%) against transmembrane serine protease 2; compounds 3, 5, 8, 9, and 17 showed strong inhibition rates (63.89%-83.75%) against transmembrane serine protease 2; compounds 5 and 8 with inhibition rates greater than 75% were tested for their IC 50 , and obtained their half-inhibitory concentrations, respectively: Compound 5N-(4-N,N-diethylbenzoyl) artemisinic acid hydrazide IC 50 =31.40nM( Figure 1 ); Compound 8N-(4-pyridinecarbonyl) artemisia ketone acid hydrazide IC 50 =26.29nM( Figure 2 ).
Claims
1. A hydrazide derivative of Artemisia selengensis ketoacid, It is characterized in that The structural formula of the derivative is: in: Compound 1 is: N-benzoyl artemisinic acid hydrazide; Compound 2 is: N-(4-trifluoromethylbenzoyl) artemisinic acid hydrazide; Compound 3 is: N-(4-methylbenzoyl) artemisinic acid hydrazide; Compound 4 is: N-(4-methoxybenzoyl) artemisinic acid hydrazide; Compound 5 is: N-(4-N,N-diethylbenzoyl) artemisia acid hydrazide; Compound 6 is: N-indolecarboxylic acid hydrazide; Compound 7 is: N-(4-tert-butylbenzoyl) artemisinic acid hydrazide; Compound 8 is: N-(4-pyridinyl) artemisinic acid hydrazide; Compound 9 is: N-(3-pyridinyl) artemisinic acid hydrazide; Compound 10 is: N-(4-hydroxybenzoyl) artemisinic acid hydrazide; Compound 11 is: N-(4-fluorobenzoyl) artemisinic acid hydrazide; Compound 12 is: N-(4-iodobenzoyl) artemisinic acid hydrazide; Compound 13 is: N-(4-chlorobenzoyl) artemisinic acid hydrazide; Compound 14 is: N-(4-trifluoromethylbenzoyl) artemisinic acid hydrazide; Compound 15 is: N-(4-cyanobenzoyl) artemisinic acid hydrazide; Compound 16 is: N-(4-acetylaminobenzoyl) artemisinic acid hydrazide; Compound 17 is: N-tert-butyl formate-artemisinic acid hydrazide; Compound 18 is: N-(2,4,6-trichlorophenyl) artemisinic acid hydrazide; Compound 19 is: N-(4-chlorophenyl) artemisinic acid hydrazide; Compound 20 is: N-(4-methylphenyl) artemisinic acid hydrazide; Compound 21 is: N-(4-iodophenyl) artemisinic acid hydrazide; Compound 22 is: N-(4-tert-butylphenyl) artemisinic acid hydrazide; Compound 23 is: N-(4-ethylphenyl) artemisinic acid hydrazide; Compound 24 is: N-(4-methoxyphenyl) artemisinic acid hydrazide; Compound 25 is: N-(4-bromophenyl) artemisinic acid hydrazide; Compound 26 is: N-(4-nitrophenyl) artemisinic acid hydrazide; Compound 27 is: N-(4-fluorophenyl) artemisinic acid hydrazide; Compound 28 is: N-(4-trifluoromethoxyphenyl) artemisinic acid hydrazide; Compound 29 is: N-(4-cyanophenyl) artemisinic acid hydrazide; Compound 30 is: N-(4-isopropylphenyl) artemisinic acid hydrazide; Compound 31 is: N-(2,6-dichlorophenyl) artemisinic acid hydrazide; Compound 32 is: N-(4-ethylbenzoyl) artemisinic acid hydrazide; Compound 33 is: N-(4-N,N-dimethylbenzoyl) artemisinic acid hydrazide; Compound 34 is: N-(2-pyridyl)artemisinic acid hydrazide.
2. The method for preparing the artemisia ketoacid hydrazide derivatives according to claim 1, Features According to the general formula (I) The naturally extracted artemisia ketoacid and hydrazine (acylhydrazide) compounds are subjected to condensation and dehydration to obtain a series of artemisia ketoacid acylhydrazide derivatives; the specific operation is carried out according to the following steps: Dissolve 0.2mmol, 49.6mg of naturally extracted Artemisia selengensis ketone acid and 0.4mmol of hydrazine or hydrazide in 3mL of dry ethyl acetate, place in an ice bath at 0℃, add 1mL of pyridine, 0.4mmol of 1-n-propylphosphoric anhydride 50% ethyl acetate, 0.23mL solution in sequence, stir for 16h, and naturally warm to room temperature during stirring. After the reaction, quench the reaction with 0.5M hydrochloric acid in an ice bath at 0℃, extract with ethyl acetate 3 times, combine the organic layers, dry the organic layers with anhydrous sodium sulfate, spin dry the solvent, use 200-300 mesh silica gel as the stationary phase, and a mixed solution of ethyl acetate: petroleum ether in a volume ratio of 1:5 as the mobile phase, and purify by column chromatography to obtain the target derivative.
3. According to claim 1, the use of the hydrazide derivatives of Artemisia serine monophosphate in the preparation of drugs for preventing and treating coronavirus, wherein compounds 1, 7, 10, 12, 13, 24, 24, 25, 26, 27, and 29 show a weak inhibition rate of 12.31%-29.80% on transmembrane serine protease 2; compounds 2, 4, 6, 11, 14, 15, 16, 18, 19, 20, 21, 22, 23, 28, 30, 31, 32, 33, and 34 show a strong inhibition rate of 30.94%-58.88% on transmembrane serine protease 2; compounds 3, 5, 8, 9, and 17 show a strong inhibition rate of 63.89%-83.75% on transmembrane serine protease 2.
